A comprehensive review of the protein subunit vaccines against COVID-19

M Heidary, VH Kaviar, M Shirani, R Ghanavati… - Frontiers in …, 2022 - frontiersin.org
Two years after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …

Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID

E Hadley, YJ Yoo, S Patel, A Zhou, B Laraway… - Communications …, 2024 - nature.com
Background Although the COVID-19 pandemic has persisted for over 3 years, reinfections
with SARS-CoV-2 are not well understood. We aim to characterize reinfection, understand …

[HTML][HTML] Cardiovascular complications of COVID-19: a scoping review of Evidence

A Ntchana, S Shrestha, M Pippin - Cureus, 2023 - ncbi.nlm.nih.gov
This scoping review sought to identify the nature and extent of clinical evidence regarding
the acute and long-term cardiovascular complications associated with COVID-19. Forty-nine …

Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study

SF Mousavi, M Ebrahimi, SAA Moghaddam, N Moafi… - Vacunas, 2023 - Elsevier
Background Nowadays, the world is facing a coronavirus disease (COVID-19) pandemic,
elicited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At the time …

Rate and risk factors of Reinfection, recurrence, and Hospital Readmission among SARS-Cov-2 hospitalized patients; a National Cohort Study

N Taherpour, K Etemad, Y Mokhayeri… - Archives of …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction: Reinfection and hospital readmission due to COVID-19 were significant and
costly during the pandemic. This study aimed to assess the rate and risk factors of SARS …

Comparative analysis of C-Reactive protein levels among Non-comorbid, Comorbid, and Multimorbid Hospitalized COVID-19 patients

M Shoukat, H Khan, M Nazish, A Rehman… - BMC Infectious …, 2025 - Springer
Background C-reactive protein (CRP) is one of the most commonly monitored inflammatory
markers in patients with COVID-19 to gain insight into the inflammation level in the body and …

Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a …

JA Bailón-Cuenca, K Cortés-Sarabia… - BMC Infectious …, 2024 - Springer
Background Natural infection and vaccination against SARS-CoV-2 is associated with the
development of immunity against the structural proteins of the virus. Specifically, the two …

The potential role of telemedicine in the infectious disease pandemic with an emphasis on COVID‐19: A narrative review

F Shokri, S Bahrainian, F Tajik, E Rezvani… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aims Due of its low cost, rapid speed, data record, and vast
communication coverage, information and communication technology might be useful for …

Milder outcomes of SARS-CoV-2 genetically confirmed reinfections compared to primary infections with the delta variant: a retrospective case-control study

A Suljič, M Sočan, M Mrzel, MM Lunar, M Korva… - Frontiers in …, 2022 - frontiersin.org
Background SARS-CoV-2 infection does not confer long immunity. However, studies
suggest that prior infection is associated with lower risk of reinfection and milder outcomes of …

Estimation of outpatient SARS-CoV-2 reinfection and recurrence rates and associated factors among COVID-19 hospitalized patients over one-year old: a multicenter …

Y Mokhayeri, N Taherpour, F Shahbazi… - BMC Infectious …, 2024 - Springer
Abstract Introduction Reinfection with SARS-Cov-2 after recovery can occur that most of
them don't require hospitalization. The aim of this study is estimation of out-patient COVID …